Kronik Obstrüktif Akciğer Hastalığı Anksiyete Ölçeğinin Türkçe Geçerlik ve Güvenirlik Çalışması

Abstract

Amaç: Bu araştırma, Kronik Obstrüktif Akciğer Hastalığı (KOAH) Anksiyete Ölçeğinin Türkçe geçerliğini ve güvenirliğini belirlemek amacıyla yürütüldü. Materyal ve Metot: Metodolojik türde olan araştırmanın örneklemini Atatürk Üniversitesi Sağlık Araştırma ve Uygulama Merkezi ve Erzurum Şehir Hastanesi göğüs hastalıkları kliniğinde tedavi gören 401 hasta oluşturdu. Veri toplama araçları olarak, Tanımlayıcı Özellikler Formu, KOAH Anksiyete Ölçeği, KOAH Değerlendirme Testi, Modified Medical Research Council Dyspnea Skalası (mMRC), ve Hastane Anksiyete ve Depresyon Ölçeği kullanıldı. Madde toplam korelasyonu, açıklayıcı ve doğrulayıcı faktör analizi, Kaiser-Meyer-Olkin testi ve Bartlett's Küresellik testi, test-tekrar test güvenirliği, paralel formlar güvenirliği, Cronbach alfa katsayısı hesaplandı. Bulgular: Ölçekte bulunan maddelerin madde toplam korelasyon değerlerinin 0.36-0.64 arasında olduğu saptandı. KMO değerinin 0.854 olduğu, Bartlett's Küresellik testinin anlamlı olduğu saptandı (p<0.05). Ölçeğin 18 madde ve beş alt boyuttan oluştuğu saptandı. Ölçeğin açıklanan varyans oranının %81.596 olduğu görüldü. Doğrulayıcı faktör analizi uyum indekslerinin CFI=0.950, RMSEA=0.078 olduğu belirlendi. Ölçeğin Cronbach Alpha katsayısının 0.90, alt boyutlarının Cronbach Alpha katsayılarının 0.78 ile 0.93 arasında olduğu saptandı. Ölçeğin zamana karşı değişmezliğinde kararlı bir ölçüm aracı olduğu bulundu. KOAH Anksiyete Ölçeği ve alt boyutları ile KOAH Değerlendirme Testi, Modified Medical Research Council Dispne Skalası (mMRC), Hastane Anksiyete ve Depresyon Ölçeği arasında pozitif yönde bir ilişki olduğu belirlendi (p<0.05). Sonuç: KOAH Anksiyete Ölçeğinin Türkçe versiyonunun geçerli ve güvenilir bir ölçüm aracı olduğu, KOAH’a özgü anksiyetenin değerlendirilmesinde kullanılabileceği sonucuna varıldı.

Keywords

• Anksiyete
• geçerlik
• güvenirlik
• hemşire
• KOAH
• ölçek uyarlama.

Validity and Reliability of the Turkish Version of the Chronic Obstructive Pulmonary Disease Anxiety Scale

Abstract

Objective: This study was conducted to determine the Turkish validity and reliability of the Chronic Obstructive Pulmonary Disease (COPD) Anxiety Scale. Methods: The sample of the methodological study consisted of 401 patients treated in the Atatürk University Health Research and Application Centre and the Erzurum City Hospital chest diseases clinic. The Descriptive Characteristics Form, COPD Anxiety Scale, COPD Assessment Test (CAT), Modified Medical Research Council Scale (mMRC), and Hospital Anxiety and Depression Scale (HADS) were used as data collection tools. Item-total correlation, exploratory and confirmatory factor analysis, Kaiser-Meyer-Olkin test, Bartlett's Sphericity test, test-retest reliability, parallel forms reliability, and Cronbach's alpha coefficient were calculated. Results: Item-total correlations ranged from 0.36 to 0.64. The Kaiser-Meyer-Olkin value was 0.854, and Bartlett’s test was significant (p<0.05). The scale consists of 18 items and 5 sub-dimensions. The total explained variance was 81.596%. Confirmatory factor analysis fit indices were CFI=0.950 and RMSEA=0.078. Cronbach’s alpha was 0.90 for the whole scale and between 0.78 and 0.93 for the sub-dimensions. The scale was found to be a stable measurement tool with time invariance. The scale and its sub-dimensions showed positive correlations with CAT, mMRC, and HADS (p<0.05). The COPD Anxiety Scale and its sub-dimensions showed positive correlations with CAT, mMRC, and HADS (p<0.05). Conclusion: The Turkish version of the COPD Anxiety Scale is a valid and reliable measurement tool that can be used to evaluate COPD-specific anxiety.

Keywords

• Anxiety
• COPD
• nurse
• reliability
• scale adaptation
• validity.

References

1. Adeloye, D., Song, P., Zhu, Y., Campbell, H., Sheikh, A., & Rudan, I. (2022). Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: A systematic review and modelling analysis. The Lancet Respiratory Medicine, 10(5), 447-458.https://doi.org/10.1016/S2213-2600(21)00511-7
2. Agustí, A., Celli, B. R., Criner, G. J., Halpin, D., Anzueto, A., Barnes, P., ... & Vogelmeier, C. F. (2023). Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. European Respiratory Journal, 61(4). https://doi.org/10.1183/13993003.00239-2023
3. Agustí, A., Vogelmeier, C., & Faner, R. (2020). COPD 2020: Changes and challenges. American Journal of Physiology-Lung Cellular and Molecular Physiology, 319(5), L879-L883. https://doi.org/10.1152/ajplung.00429.2020
4. Alpar, R. (2018). Uygulamalı istatistik ve geçerlik-güvenirlik. Geçerlik Güvenirlik (5. baskı, s. 493-560). Detay Yayıncılık.
5. Aydemir, Güvenir, T., Küey, L., & Kültür, S. (1997). Reliability and Validity of the Turkish version of Hospital Anxiety and Depression Scale. Turkish Journal of Psychiatry, 8, 187-280.
6. Ayre, C., & Scally, A. J. (2014). Critical values for Lawshe’s content validity ratio: revisiting the original methods of calculation. Measurement and Evaluation in Counseling and Development, 47(1), 79-86. https://doi.org/10.1177/0748175613513808
7. Avci, E. (2022). Bayesian Meta-Analysis of Cronbach's Alpha Coefficient in Hypothesis Testing: A Methodological Research. Turkiye Klinikleri Journal of Biostatistics, 14(3), 180-189, https://doi.org/10.5336/biostatic.2022-88576
8. Bae, B. R. (2017). Structural equation modeling with Amos 24. Chenngram Books, 76-309.

9. Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
10. Bestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. (1999). Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax, 54(7), 581-586. https://doi.org/10.1136/thx.54.7.581
11. Boone, W. J., & Staver, J. R. (2020). Advances in Rasch analyses in the human sciences (pp. 287-302). Cham, Switzerland: Springer. https://doi.org/10.1007/978-3-030-43420-5
12. Bugajski, A., Morgan, H., Wills, W., Jacklin, K., Alleyne, S., Kolta, B., Lengerich, A., & Rechenberg, K. (2023). Anxiety and depressive symptoms in patients with COPD: Modifiable explanatory factors. Western Journal of Nursing Research, 45(4), 316–326. https://doi.org/10.1177/01939459221129949
13. Cruchinho P, López-Franco MD, Capelas ML, Almeida S, Bennett PM, Miranda da Silva M, Teixeira G, Nunes E, Lucas P, Gaspar F; Handovers 4SafeCare. (2024). Translation, Cross-Cultural Adaptation, and Validation of Measurement Instruments: A Practical Guideline for Novice Researchers. Journal of Multidisciplinary Healthcare, 31(17), 2701-2728. https://doi.org/10.2147/JMDH.S419714
14. Çakmur, H. (2012). Measurement-reliability-validity in research. TAF Preventive Medicine Bulletin, 11(3), 339-344. https://doi.org/10.5455/pmb.1-1322486024
15. Çapik, C., Gözüm, S., & Aksayan, S. (2018). Intercultural scale adaptation stages, language and culture adaptation: updated guideline. Florence Nightingale Journal of Nursing-Florence Nightingale Hemsirelik Dergisi, 26(3).
16. Farver-Vestergaard, I., Rubio-Rask, S., Timm, S., Christiansen, C. F., Hilberg, O., & Løkke, A. (2022). Disease-specific anxiety in chronic obstructive pulmonary disease: Translation and initial validation of a questionnaire. Frontiers in Psychology, 13, 907939. https://doi.org/10.3389/fpsyg.2022.907939
17. Flecher, C. M. (1952). The clinical diagnosis of pulmonary emphysema-an experimental study. Proceedings of the Royal Society of Medicine, 45, 577-584.
18. GOLD. (2024, May 10). Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD. http://goldcopd.org.
19. Huang, J., Bian, Y., Zhao, Y., Jin, Z., Liu, L., & Li, G. (2021). The Impact of Depression and Anxiety on Chronic Obstructive Pulmonary Disease Acute Exacerbations: A prospective cohort study. Journal of Affective Disorders, 281, 147–152. https://doi.org/10.1016/j.jad.2020.12.030
20. Hurtado-Ruzza, R., Álvarez-Calderón-Iglesias, Ó., Becerro-de-Bengoa-Vallejo, R., Calvo-Lobo, C., San-Antolín, M., Losa-Iglesias, M. E., ... & López-López, D. (2022). Self-reported depression and anxiety among COPD patients. A case-control study. Sao Paulo Medical Journal, 140, 207-212. https://doi.org/10.1590/1516-3180.2021.0235.r1.17062021
21. Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W. H., & Leidy, N. K. (2009). Development and first validation of the COPD Assessment Test. European Respiratory Journal, 34(3), 648-654. https://doi.org/10.1183/09031936.00102509
22. Karaçam, Z. (2019). Adaptatıon of scales to Turkısh. Journal of Midwifery and Health Sciences, 2(1), 28-37.
23. Karakoç, F. Y., & Dönmez, L. (2014 Basic Principles of Scale Development. Tıp Eğitimi Dünyası, 13(40), 39-49. https://doi.org/10.25282/ted.228738
24. Keil, D. C., Stenzel, N. M., Kühl, K., Vaske, I., Mewes, R., Rief, W., & Kenn, K. (2014). The impact of chronic obstructive pulmonary disease-related fears on disease-specific disability. Chronic Respiratory Disease, 11(1), 31-40. https://doi.org/10.1177/1479972313516881
25. Kılıç, A., & Koyuncu, İ. (2017). Ölçek uyarlama çalışmalarının yapı geçerliği açısından incelenmesi. In Küreselleşen Dünyada Eğitim. Pegem Akademi, pp.415-438. https://doi.org/10.14527/9786053188407.27
26. Kline, P. (2014). An easy guide to factor analysis. Routledge. https://doi.org/10.4324/9781315788135
27. Koo, T. K., Li, M. Y. A. (2016). Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. Journal of Chiropractic Medicine, 15(2), 155-63. https://doi.org/10.1016/j.jcm.2016.02.012
28. Kühl, K., Kuhn, C., Kenn, K., & Rief, W. (2011). The COPD-Anxiety-Questionnaire (CAF): A new instrument to assess illness specific anxiety in COPD patients. Psychotherapie, Psychosomatik, Medizinische Psychologie, 61(01), e1-e9. https://doi.org/10.1055/s-0030-1248281
29. Lima, C. A., Oliveira, R. C., Oliveira, S. A. G., Silva, M. A. S. D., Lima, A. A., Andrade, M. S., & Pinho, C. M. (2020). Quality of life, anxiety and depression in patients with chronic obstructive pulmonary disease. Revista Brasileira de Enfermagem, 73(Suppl 1), e20190423. https://doi.org/10.1590/0034-7167-2019-0423
30. Miao, X., Han, Y., Wu, Z., Jin, X., Niu, M. E., Zhao, Q., & Lu, X. (2024). Reliability, validity, modification and expansion of the Chinese version of the disease-specific anxiety questionnaire for chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease, 1047-1060. https://doi.org/10.2147/COPD.S455171 Martínez-Gestoso, S., García-Sanz, M. T., Carreira, J. M., Salgado, F. J., Calvo-Álvarez, U., Doval-Oubiña, L., ... & González-Barcala, F. J. (2022). Impact of anxiety and depression on the prognosis of COPD exacerbations. BMC Pulmonary Medicine, 22(1), 169.https://doi.org/10.1186/s12890-022-01934-y
31. Murray, C. J. L. (2022). The global burden of disease study at 30 years. Nature Medicine, 28(10), 2019–2026. https://doi.org/10.1038/s41591-022-01990-1
32. Orçan, F. (2018). Exploratory and Confirmatory Factor Analysis: Which One to Use First? Journal of Measurement and Evaluation in Education and Psychology, 9(4), 414-421.
33. Öner, N. (2009). Türkiye'de kullanılan psikolojik testler: Bir başvuru kaynağı (2. baskı). Boğaziçi Matbaa.
34. Pallant, J. (2020). SPSS survival manual: A step by step guide to data analysis using IBM SPSS. Routledge. (3. baskı). McGraw-hill education (UK).
35. Rahi, M. S., Thilagar, B., Balaji, S., Prabhakaran, S. Y., Mudgal, M., Rajoo, S., ... & Gunasekaran, K. (2023). The impact of anxiety and depression in chronic obstructive pulmonary disease. Advances in Respiratory Medicine, 91(2), 123-134. https://doi.org/10.3390/arm91020011
36. Seçer, İ. (2020). Psikolojik Test Geliştirme ve Uyarlama Süreci: SPSS ve LISREL Uygulamaları. Anı Yayıncılık.
37. Singh, G., Zhang, W., Kuo, Y. F., & Sharma, G. (2016). Association of psychological disorders with 30-day readmission rates in patients with COPD. Chest, 149(4), 905–915. https://doi.org/10.1378/chest.15-0449
38. Spielberger, C. D., Gorsuch, R. L., Lushene, R. E., Vagg, P. R., & Jacobs, G. A. (1970). State-trait anxiety inventory, manual for the state-trait anxiety inventory. Consulting Psychologist Press, 1-18.
39. Spitzer, R. L., Kroenke, K., Williams, J. B., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of İnternal Medicine, 166(10), 1092-1097. https://doi.org/10.1001/archinte.166.10.1092
40. Şimşek, Ö. F. (2007). Yapısal eşitlik modellemesine giriş: Temel ilkeler ve LISREL uygulamaları. Ekinoks Yayınları.
41. Tabar, N.A., Al Qadire, M., Thultheen, I., & Alshraideh, J. (2021). Health-related quality of life, uncertainty, ‎and anxiety among patients with chronic obstructive pulmonary disease. F1000 Research, 10, 420. https://doi.org/10.12688/f1000research.51936.1
42. Ţîrcă, S. M., Ciontea, M. S., Vlad, E., & Mihălţan, F. D. (2021). Distant compliance with treatment in patients with chronic respiratory diseases: asthma, COPD and asthma-COPD overlap syndrome. prospective study. Internal Medicine, 18(2), 15-47. https://doi.org/10.2478/inmed-2021-0155
43. Uyumaz, G., & Sırgancı, G. (2020). What is the required sample size for confirmatory factor analysis?: Bayesian approach and maximum likelihood estimation. International Journal of Society Researches, 16(32), 5302–5340.
44. Vikjord, S. A. A., Brumpton, B. M., Mai, X. M., Vanfleteren, L., & Langhammer, A. (2020). The association of anxiety and depression with mortality in a COPD cohort. The HUNT study, Norway. Respiratory Medicine, 171, 106089. https://doi.org/10.1016/j.rmed.2020.106089
45. Willgoss, T. G., Goldbart, J., Fatoye, F., & Yohannes, A. M. (2013). The development and validation of the anxiety inventory for respiratory disease. Chest, 144(5), 1587-1596. https://doi.org/10.1378/chest.13-0168
46. Yeşilyurt, S., & Çapraz, C. (2018). A Road Map for the Content Validity Used in Scale Development Studies. Erzincan University Journal of Education Faculty, 20(1), 251-264. https://doi.org/10.17556/erziefd.297741
47. Yohannes, A.M., & Alexopoulos, G.S. (2014). Depression and anxiety in patients with COPD. European Respiratory Review, (23). 345–349. doi: 10.1183/09059180.00007813.
48. Yohannes, A. M., Murri, M. B., Hanania, N. A., Regan, E. A., Iyer, A., Bhatt, S. P., ... & COPD Gene Investigators. (2022). Depressive and anxiety symptoms in patients with COPD: A network analysis. Respiratory Medicine, 198, 106865. https://doi.org/10.1016/j.rmed.2022.106865
49. Yorgancioğlu, A., Polatli, M., Aydemir, Ö., Demirci, N. Y., Kirkil, G., Atiş, S. N., ... & Günakan, G. (2012). Reliability and validity of Turkish version of COPD assessment test. Tuberk Toraks, 60(4), 314-20. https://doi.org/10.5578/tt.4321
50. Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361-370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x